Access cutting-edge blood cancer treatment through this clinical trial at a research site in Stony Brook. Study-provided care at no cost to qualified participants.
Access blood cancer specialists in Stony Brook at no cost
This study follows strict safety protocols and ethical guidelines
All study-related blood cancer treatment provided free
This phase 2 trial studies the immune response to GEO-CM04S1 (previously designated as COH04S1) compared to standard of care (SOC) mRNA SARS-COV-2 vaccine in patients with blood cancer who have received stem cell transplant or cellular therapy. GEO-CM04S1 belongs to a category called modified vaccinia Ankara (MVA) vaccines, created from a new version of MVA, called synthetic MVA. GEO-CM04S1 works by inducing immunity (the ability to recognize and fight against an infection) to SARS-CoV-2. The i
Sponsor: GeoVax, Inc.
Check if you qualify for this blood cancer clinical trial in Stony Brook, NY
If you're searching for blood cancer treatment options in Stony Brook, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stony Brook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.